Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Azacitidine in lower-risk myelodysplastic syndromes.

    ... 50% in lower-risk patients; most patients who achieved transfusion independence were also lower-risk. A further retrospective study reported ...

    Research Article last updated 10/11/2011 - 5:58pm.

  2. Eltrombopag and improved hematopoiesis in refractory aplastic anemia

    ... were clinically significant changes in blood counts or transfusion independence . Patients with a response continued to receive eltrombopag. ...

    Research Article last updated 07/31/2012 - 2:24pm.

  3. Engraftment of heavily transfused patients with severe aplastic anemia with a fludarabine-based regimen

    ... in total, 77 patients showed durable engraftment and transfusion independence , and 64 are alive at a median time of 49 months with an ...

    Research Article last updated 03/05/2013 - 8:04am.

  4. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies

    ... leading to hemoglobin stabilization and transfusion independence in more than half of the patients. However, recent ...

    Research Article last updated 03/05/2013 - 9:38am.

  5. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies

    ... leading to hemoglobin stabilization and transfusion independence in more than half of the patients. However, recent ...

    Research Article last updated 10/02/2012 - 9:57am.

  6. Long term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival.

    ... (66%) patients on treatment for over 12 months achieved transfusion independence on eculizumab. The mean transfusion requirement reduced by ...

    Research Article last updated 10/11/2011 - 5:58pm.

  7. Nursing Education Modules on MDS Disease Management and Patient Education

    ... therapy, minimal toxicity, improvement of blood counts, transfusion independence , delay of leukemic transformation, improved survival, quality ...

    Page last updated 04/27/2015 - 2:44pm.

  8. A Phase 1 Study of Oral ARRY-614, a p38 MAPK/Tie2 Dual Inhibitor, in Patients with Low or Intermediate 1 Risk Myelodysplastic Syndromes

    ... patients experiencing bilineage responses. Three of 25 RBC transfusion-dependent (TD) patients achieved transfusion independence (TI) and 5 of 7 platelet TD patients achieved TI. ...

    Research Article last updated 01/20/2015 - 1:07pm.

  9. Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy

    ... the health-related quality of life (HRQOL) in lower-risk, transfusion-dependent patients with myelodysplastic syndromes (MDS) ... predictive factor of an earlier achievement of transfusion independence with a HR of 1.032 (99% CI 1.004 to 1.060; p=0.003). ...

    Research Article last updated 09/24/2014 - 10:50am.

  10. Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

    ... remission, hematologic improvement, or RBC or platelet transfusion independence) was 35% in previously treated patients and 73% in previously ...

    Research Article last updated 10/11/2011 - 5:58pm.